Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy

Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy

Background/Aims Prolonged dual antiplatelet therapy (DAPT) with aspirin and clopidogrel beyond 1 year has been shown to reduce ischemic events at the expense of increased bleeding. However, limited data are available on the clinical significance of platelet reactivity (PR) at 1 year. Methods We retr...

Full description

Bibliographic Details
Main Authors:	Sehun Kim, Donghoon Han, Jae Hyuk Choi, Eun-Joo Park, Dong Geum Shin, Min-Kyung Kang, Seonghoon Choi, Namho Lee, Jung Rae Cho
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2021-03-01
Series:	The Korean Journal of Internal Medicine
Subjects:	dual anti-platelet therapy percutaneous coronary intervention platelet function tests retrospective study
Online Access:	http://www.kjim.org/upload/pdf/kjim-2020-085.pdf

Similar Items

Sepsis favors high-on-clopidogrel platelet reactivity
by: Karolina Akinosoglou, et al.
Published: (2018-01-01)

Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
by: Yang Zhang, et al.
Published: (2021-12-01)

Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
by: W. Bouida, et al.
Published: (2017-06-01)

The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis
by: Zhiyan Liu, et al.
Published: (2020-01-01)

Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation
by: Yalçın Velibey, et al.
Published: (2018-07-01)

The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review
by: Adam Wiśniewski, et al.
Published: (2020-09-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention
by: Pei Zhu, et al.
Published: (2019-10-01)

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment
by: Shushu Yu, et al.
Published: (2023-07-01)

Impact of platelet endothelial aggregation receptor 1 genotypes and DNA methylation on platelet reactivity in patients with recurrent ischemic stroke treated with clopidogrel
by: Jiahui Yang, et al.
Published: (2023-02-01)

The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2023-05-01)

Mass cytometry of platelet-rich plasma: a new approach to analyze platelet surface expression and reactivity
by: Melissa Klug, et al.
Published: (2022-08-01)

Reticulated Platelets in Medicine: Current Evidence and Further Perspectives
by: Noé Corpataux, et al.
Published: (2020-11-01)

Prevalence of platelet reactive antibodies in patient′s refractory to platelet transfusions
by: Nitin Agarwal, et al.
Published: (2014-01-01)

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2023-07-01)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
by: Thomas W. Johnson, et al.
Published: (2020-12-01)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
by: Yingying Yang, et al.
Published: (2020-06-01)

Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2022-09-01)

Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention
by: Matteo Nardin, et al.
Published: (2023-09-01)

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
by: J.F.M. Marchini, et al.

Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery
by: Torbjörn Ivert, et al.
Published: (2019-11-01)

Platelet reactivity after clopidogrel loading in patients with acute ischemic stroke
by: Yukiko Enomoto, et al.
Published: (2022-08-01)

Impact of On-Clopidogrel Platelet Reactivity on Incidence of Peri-Interventional Bleeding in Patients Undergoing Transcatheter Aortic Valve Implantation
by: Alexander Kille, et al.
Published: (2022-05-01)

High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women
by: Kate A. Wickham, et al.
Published: (2022-10-01)

Lyophilized platelets inhibit platelet aggregation with simultaneous paradoxical promotion of platelet adhesion
by: Brian Schnoor, et al.
Published: (2022-08-01)

Comparison of changes in platelet count, mean platelet volume and swirling in stored platelet concentrates with and without platelet additive solution
by: Saira Bashir, et al.
Published: (2014-01-01)

Clopidogrel use and smoking cessation result in lower coated-platelet levels after stroke
by: Angelia C. Kirkpatrick, et al.
Published: (2020-02-01)

Frozen and cold-stored platelets: reconsidered platelet products
by: Teresa Jimenez-Marco, et al.
Published: (2022-01-01)

Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrel
by: Huaibin Wan, et al.
Published: (2021-10-01)

Inhibition of Platelets by Clopidogrel Suppressed Ang II‐Induced Vascular Inflammation, Oxidative Stress, and Remodeling
by: Xiangbo An, et al.
Published: (2018-11-01)

Large-Scale Profiling on lncRNAs in Human Platelets: Correlation with Platelet Reactivity
by: Yeying Sun, et al.
Published: (2022-07-01)

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
by: Monica Verdoia, et al.
Published: (2019-10-01)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Diona Gjermeni, et al.
Published: (2022-07-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

Dose- and time-related platelet response with apheresis platelet concentrates and pooled platelets
by: Mohammad Mizanur Rahman, et al.
Published: (2017-02-01)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
by: Stefan Handtke, et al.
Published: (2018-02-01)

The Relationship Between Platelet, Mean Platelet Volume, C-Reactive Protein and Mortality in Ischemic Stroke Patients
by: Ayhan Döner, et al.
Published: (2019-03-01)

Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study
by: Xiao-Fei Gao, et al.
Published: (2018-05-01)

Influence of diagnosis of venous thromboembolism on immature platelets, absolute platelet count and platelet aggregation over time
by: Isabel Wustrow, et al.
Published: (2021-04-01)

Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)
by: Meijiao He, et al.
Published: (2022-11-01)